trial · primary record
bi-4SCAR CD19/79b T cells
B Cell Malignancies
| Phase | Phase 1, Phase 2 |
|---|---|
| Status | TERMINATED |
| Sponsor | Unknown |
| Enrolment | 60 |
| Primary completion | 2026-07-31 |
| Primary endpoint | Safety of fourth generation bi-4SCAR-CD19/79b T cells in patients with B cell malignancies |
| Registry ID | NCT05436509 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:46:03.330Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT05436509
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.